[HTML][HTML] Immune checkpoint inhibitors: therapeutic advances in melanoma

I Marquez-Rodas, P Cerezuela, A Soria… - Annals of …, 2015 - ncbi.nlm.nih.gov
In recent years, new strategies for treating melanoma have been introduced, improving the
outlook for this challenging disease. One of the most important advances has been the …

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial

…, L de la Cruz, P Cerezuela… - Nature …, 2021 - nature.com
Combination treatment with BRAF (BRAFi) plus MEK inhibitors (MEKi) has demonstrated
survival benefit in patients with advanced melanoma harboring activating BRAF mutations. …

Smoking and nonfatal traffic accidents

…, C García, CPM Md, AP JL, M Hijar, P Cerezuela - Atención …, 2003 - europepmc.org
Objetivo. Estudiar la posible asociación entre consumo de tabaco y accidentes de tráfico no
letales, además de valorar la posible influencia de otros factores en los mismos. Diseño. …

[HTML][HTML] Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)

…, B Clotet, J Martinez-Picado, P Cerezuela… - … for ImmunoTherapy of …, 2021 - ncbi.nlm.nih.gov
Cancer immunotherapy based on the use of antibodies targeting the so-called checkpoint
inhibitors, such as programmed cell death-1 receptor, its ligand, or CTLA-4, has shown …

[HTML][HTML] Percepción de los Residentes de Medicina Familiar y Comunitaria sobre el programa formativo de la Especialidad

…, V Casado Vicente, F Pablo Cerezuela - Revista Clínica de …, 2012 - SciELO Espana
LUCAS PEREZ-ROMERO, Francisco Javier; CHACON CASO, Patricia; CASADO VICENTE,
Verónica y PABLO CEREZUELA, Francisco. Percepción de los Residentes de Medicina …

Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer

…, A Arcediano, I Barneto, P Cerezuela… - European journal of …, 2019 - Wiley Online Library
Objectives Although new therapies against metastatic cancer have been developed in recent
decades, chemotherapy is still an important treatment option. Prolonged treatment and side…

Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients

…, P Rodríguez-Jiménez, S Puig, P Cerezuela… - MedRxiv, 2020 - medrxiv.org
Background Covid-19 pandemic by the new coronavirus SARS-Cov-2 has produced devastating
effects on the health care system, affecting also cancer patient care. Data about COVID-…

Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma

…, J Trujillo-Santos, P Cerezuela-Fuentes… - Human pathology, 2010 - Elsevier
Colorectal serrated adenocarcinoma represents a subtype of colorectal carcinoma that
originates from serrated adenomas. Previous studies have suggested a more aggressive course, …

Prognostic significance of venous thromboembolic events in disseminated germ cell cancer patients

…, P Maroto, R Manneh, P Cerezuela… - JNCI: Journal of the …, 2017 - academic.oup.com
Background: Disseminated germ cell cancers are at high risk of developing thromboembolic
complications. We evaluated the prognostic value of venous thromboembolic events (VTE) …

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Espanol Multidisciplinar de Melanoma–Prima study

…, I Márquez-Rodas, I Palacio, P Cerezuela… - Melanoma …, 2016 - journals.lww.com
Adjuvant interferon-α2b (IFN-α2b) has been studied extensively in clinical trials, but there
have been few studies of real-world use. The aim of this study is to describe the IFN-α2b real-…